8.25.10FibroGen Announces Results of 2-Year Study Demonstrating that Biosynthetic Corneas Formulated with Recombinant Human Type III Collagen Restore Vision and Promote Nerve Regeneration
5.25.10Two Join Board of Directors of FibroGen, Inc.
5.17.10FibroGen Reports Preclinical Data Showing that FG-3019 Reversed the Process of Fibrosis in the Lung